vs
Side-by-side financial comparison of BREAD FINANCIAL HOLDINGS, INC. (BFH) and Dexcom (DXCM). Click either name above to swap in a different company.
Dexcom is the larger business by last-quarter revenue ($1.3B vs $975.0M, roughly 1.3× BREAD FINANCIAL HOLDINGS, INC.). On growth, Dexcom posted the faster year-over-year revenue change (21.6% vs 5.4%). Over the past eight quarters, Dexcom's revenue compounded faster (12.0% CAGR vs -0.8%).
Bread Financial Holdings, Inc. is an American publicly traded provider of private label credit cards, coalition loyalty programs, and direct marketing, derived from the capture and analysis of transaction-rich data.
Dexcom, Inc. is an American multinational healthcare company that develops, manufactures, produces and distributes a line of continuous glucose monitoring (CGM) systems for diabetes management. It operates internationally with global headquarters and R&D center in San Diego, California, U.S.A. and manufacturing facilities in Mesa, Arizona, U.S.A.; Batu Kawan, Malaysia and Athenry, County Galway, Ireland.
BFH vs DXCM — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | ||
|---|---|---|
| Revenue | $975.0M | $1.3B |
| Net Profit | — | $267.3M |
| Gross Margin | — | 62.9% |
| Operating Margin | 4.9% | 25.6% |
| Net Margin | — | 21.2% |
| Revenue YoY | 5.4% | 21.6% |
| Net Profit YoY | — | 153.6% |
| EPS (diluted) | $1.21 | $0.67 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $1.3B | ||
| Q4 25 | $975.0M | $1.3B | ||
| Q3 25 | $971.0M | $1.2B | ||
| Q2 25 | $929.0M | $1.2B | ||
| Q1 25 | $970.0M | $1.0B | ||
| Q4 24 | $925.0M | $1.1B | ||
| Q3 24 | $983.0M | $994.2M | ||
| Q2 24 | $939.0M | $1.0B |
| Q1 26 | — | $267.3M | ||
| Q4 25 | — | $267.3M | ||
| Q3 25 | $188.0M | $283.8M | ||
| Q2 25 | $139.0M | $179.8M | ||
| Q1 25 | $138.0M | $105.4M | ||
| Q4 24 | — | $151.7M | ||
| Q3 24 | $2.0M | $134.6M | ||
| Q2 24 | $133.0M | $143.5M |
| Q1 26 | — | 62.9% | ||
| Q4 25 | — | 62.9% | ||
| Q3 25 | — | 60.5% | ||
| Q2 25 | — | 59.5% | ||
| Q1 25 | — | 56.9% | ||
| Q4 24 | — | 58.9% | ||
| Q3 24 | — | 59.7% | ||
| Q2 24 | — | 62.4% |
| Q1 26 | — | 25.6% | ||
| Q4 25 | 4.9% | 25.6% | ||
| Q3 25 | 20.2% | 20.1% | ||
| Q2 25 | 18.7% | 18.4% | ||
| Q1 25 | 20.3% | 12.9% | ||
| Q4 24 | -2.9% | 17.0% | ||
| Q3 24 | 4.1% | 15.3% | ||
| Q2 24 | 19.2% | 15.7% |
| Q1 26 | — | 21.2% | ||
| Q4 25 | — | 21.2% | ||
| Q3 25 | 19.4% | 23.5% | ||
| Q2 25 | 15.0% | 15.5% | ||
| Q1 25 | 14.2% | 10.2% | ||
| Q4 24 | — | 13.6% | ||
| Q3 24 | 0.2% | 13.5% | ||
| Q2 24 | 14.2% | 14.3% |
| Q1 26 | — | $0.67 | ||
| Q4 25 | $1.21 | $0.67 | ||
| Q3 25 | $3.96 | $0.70 | ||
| Q2 25 | $2.94 | $0.45 | ||
| Q1 25 | $2.78 | $0.27 | ||
| Q4 24 | $0.08 | $0.37 | ||
| Q3 24 | $0.05 | $0.34 | ||
| Q2 24 | $2.66 | $0.35 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | ||
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $3.6B | $917.7M |
| Total DebtLower is stronger | $4.3B | — |
| Stockholders' EquityBook value | $3.3B | $2.7B |
| Total Assets | $22.7B | $6.3B |
| Debt / EquityLower = less leverage | 1.29× | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $917.7M | ||
| Q4 25 | $3.6B | $917.7M | ||
| Q3 25 | $3.8B | $1.8B | ||
| Q2 25 | $3.8B | $1.2B | ||
| Q1 25 | $4.2B | $904.9M | ||
| Q4 24 | $4.0B | $606.1M | ||
| Q3 24 | $3.5B | $621.2M | ||
| Q2 24 | $4.1B | $939.2M |
| Q1 26 | — | — | ||
| Q4 25 | $4.3B | — | ||
| Q3 25 | $3.8B | — | ||
| Q2 25 | $4.2B | — | ||
| Q1 25 | $5.1B | — | ||
| Q4 24 | $5.6B | — | ||
| Q3 24 | $4.6B | — | ||
| Q2 24 | — | — |
| Q1 26 | — | $2.7B | ||
| Q4 25 | $3.3B | $2.7B | ||
| Q3 25 | $3.3B | $2.7B | ||
| Q2 25 | $3.2B | $2.6B | ||
| Q1 25 | $3.1B | $2.3B | ||
| Q4 24 | $3.1B | $2.1B | ||
| Q3 24 | $3.1B | $2.0B | ||
| Q2 24 | $3.2B | $2.4B |
| Q1 26 | — | $6.3B | ||
| Q4 25 | $22.7B | $6.3B | ||
| Q3 25 | $21.7B | $7.5B | ||
| Q2 25 | $21.8B | $7.3B | ||
| Q1 25 | $22.4B | $6.8B | ||
| Q4 24 | $22.9B | $6.5B | ||
| Q3 24 | $21.7B | $6.4B | ||
| Q2 24 | $22.1B | $6.8B |
| Q1 26 | — | — | ||
| Q4 25 | 1.29× | — | ||
| Q3 25 | 1.14× | — | ||
| Q2 25 | 1.34× | — | ||
| Q1 25 | 1.67× | — | ||
| Q4 24 | 1.82× | — | ||
| Q3 24 | 1.47× | — | ||
| Q2 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | ||
|---|---|---|
| Operating Cash FlowLast quarter | $568.0M | — |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $568.0M | $294.0M | ||
| Q3 25 | $605.0M | $659.9M | ||
| Q2 25 | $526.0M | $303.0M | ||
| Q1 25 | $393.0M | $183.8M | ||
| Q4 24 | $479.0M | $301.4M | ||
| Q3 24 | $456.0M | $199.5M | ||
| Q2 24 | $477.0M | $279.4M |
| Q1 26 | — | — | ||
| Q4 25 | — | $192.1M | ||
| Q3 25 | — | $579.4M | ||
| Q2 25 | — | $208.9M | ||
| Q1 25 | — | $96.8M | ||
| Q4 24 | — | $176.8M | ||
| Q3 24 | — | $88.3M | ||
| Q2 24 | — | $213.3M |
| Q1 26 | — | — | ||
| Q4 25 | — | 15.3% | ||
| Q3 25 | — | 47.9% | ||
| Q2 25 | — | 18.1% | ||
| Q1 25 | — | 9.3% | ||
| Q4 24 | — | 15.9% | ||
| Q3 24 | — | 8.9% | ||
| Q2 24 | — | 21.2% |
| Q1 26 | — | — | ||
| Q4 25 | — | 8.1% | ||
| Q3 25 | — | 6.7% | ||
| Q2 25 | — | 8.1% | ||
| Q1 25 | — | 8.4% | ||
| Q4 24 | — | 11.2% | ||
| Q3 24 | — | 11.2% | ||
| Q2 24 | — | 6.6% |
| Q1 26 | — | — | ||
| Q4 25 | — | 1.10× | ||
| Q3 25 | 3.22× | 2.33× | ||
| Q2 25 | 3.78× | 1.69× | ||
| Q1 25 | 2.85× | 1.74× | ||
| Q4 24 | — | 1.99× | ||
| Q3 24 | 228.00× | 1.48× | ||
| Q2 24 | 3.59× | 1.95× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.